Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23748073 | 0.89 | — | — | |
| SCHEMBL30080522 | 0.86 | — | — | |
| SCHEMBL23748048 | 0.86 | LMNA (0.34) | CNR2LMNAHTT | |
| Hydrochloric Acid SCHEMBL30080645 | 0.85 | — | — | |
| SCHEMBL29774751 | 0.80 | CNR2 (0.32) | CNR2ACSS2 | |
| SCHEMBL21931657 | 0.80 | CNR2 (0.32) | CNR2ACSS2 | |
| SCHEMBL20393625 | 0.80 | NR1H2 (0.30) | NR1H2 | |
| SCHEMBL30472296 | 0.79 | KDM4E (0.30) | — | |
| SCHEMBL25886931 | 0.79 | KDM4E (0.30) | — | |
| SCHEMBL21796228 | 0.78 | ACSS2 (0.31) | ACSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210380611-A1 | PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380611-A1 | PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES | CYP4B1, MAOB, CYP3A4 | CNR2 4069/4885ACSS2 3940/4885LMNA 1894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.